These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 23706412)

  • 1. Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia.
    Reid MA; Kraguljac NV; Avsar KB; White DM; den Hollander JA; Lahti AC
    Schizophr Res; 2013 Jul; 147(2-3):348-54. PubMed ID: 23706412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal analysis of the hippocampus in schizophrenia using proton magnetic resonance spectroscopy and functional magnetic resonance imaging.
    Hutcheson NL; Reid MA; White DM; Kraguljac NV; Avsar KB; Bolding MS; Knowlton RC; den Hollander JA; Lahti AC
    Schizophr Res; 2012 Sep; 140(1-3):136-42. PubMed ID: 22831772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamatergic and Neuronal Dysfunction in Gray and White Matter: A Spectroscopic Imaging Study in a Large Schizophrenia Sample.
    Bustillo JR; Jones T; Chen H; Lemke N; Abbott C; Qualls C; Stromberg S; Canive J; Gasparovic C
    Schizophr Bull; 2017 May; 43(3):611-619. PubMed ID: 27550776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessments of function and biochemistry of the anterior cingulate cortex in schizophrenia.
    Reid MA; Stoeckel LE; White DM; Avsar KB; Bolding MS; Akella NS; Knowlton RC; den Hollander JA; Lahti AC
    Biol Psychiatry; 2010 Oct; 68(7):625-33. PubMed ID: 20570244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.
    Kraguljac NV; White DM; Reid MA; Lahti AC
    JAMA Psychiatry; 2013 Dec; 70(12):1294-302. PubMed ID: 24108440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and in vivo metabolites in first-episode neuroleptic-naive and chronic medicated schizophrenic patients: a proton magnetic resonance spectroscopy study.
    Ohrmann P; Siegmund A; Suslow T; Pedersen A; Spitzberg K; Kersting A; Rothermundt M; Arolt V; Heindel W; Pfleiderer B
    J Psychiatr Res; 2007 Oct; 41(8):625-34. PubMed ID: 16949099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging.
    Gröger A; Kolb R; Schäfer R; Klose U
    PLoS One; 2014; 9(1):e84081. PubMed ID: 24416192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolite changes and gender differences in schizophrenia using 3-Tesla proton magnetic resonance spectroscopy (1H-MRS).
    Tayoshi S; Sumitani S; Taniguchi K; Shibuya-Tayoshi S; Numata S; Iga J; Nakataki M; Ueno S; Harada M; Ohmori T
    Schizophr Res; 2009 Mar; 108(1-3):69-77. PubMed ID: 19097753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decoupling of N-acetyl-aspartate and glutamate within the dorsolateral prefrontal cortex in schizophrenia.
    Coughlin JM; Tanaka T; Marsman A; Wang H; Bonekamp S; Kim PK; Higgs C; Varvaris M; Edden RA; Pomper M; Schretlen D; Barker PB; Sawa A
    Curr Mol Med; 2015; 15(2):176-83. PubMed ID: 25732147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton magnetic resonance spectroscopy of the human brain in schizophrenia.
    Deicken RF; Johnson C; Pegues M
    Rev Neurosci; 2000; 11(2-3):147-58. PubMed ID: 10718151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain metabolite alterations in young adults at familial high risk for schizophrenia using proton magnetic resonance spectroscopy.
    Tandon N; Bolo NR; Sanghavi K; Mathew IT; Francis AN; Stanley JA; Keshavan MS
    Schizophr Res; 2013 Aug; 148(1-3):59-66. PubMed ID: 23791389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal neurometabolite levels in patients with schizophrenia undergoing long-term antipsychotic treatment: A proton magnetic resonance spectroscopy and reliability study.
    Plitman E; Chavez S; Nakajima S; Iwata Y; Chung JK; Caravaggio F; Kim J; Alshehri Y; Chakravarty MM; De Luca V; Remington G; Gerretsen P; Graff-Guerrero A
    Psychiatry Res Neuroimaging; 2018 Mar; 273():16-24. PubMed ID: 29414127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy in subjects with high genetic risk of schizophrenia: investigation of anterior cingulate, dorsolateral prefrontal cortex and thalamus.
    Yoo SY; Yeon S; Choi CH; Kang DH; Lee JM; Shin NY; Jung WH; Choi JS; Jang DP; Kwon JS
    Schizophr Res; 2009 Jun; 111(1-3):86-93. PubMed ID: 19406622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia.
    Reid MA; White DM; Kraguljac NV; Lahti AC
    Schizophr Res; 2016 Feb; 170(2-3):341-50. PubMed ID: 26718333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single voxel proton magnetic resonance spectroscopy in post-stroke depression.
    Glodzik-Sobanska L; Slowik A; McHugh P; Sobiecka B; Kozub J; Rich KE; Urbanik A; Szczudlik A
    Psychiatry Res; 2006 Dec; 148(2-3):111-20. PubMed ID: 17088051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate.
    Fayed N; Garcia-Campayo J; Magallón R; Andrés-Bergareche H; Luciano JV; Andres E; Beltrán J
    Arthritis Res Ther; 2010; 12(4):R134. PubMed ID: 20609227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher glutamate+glutamine and reduction of N-acetylaspartate in posterior cingulate according to age range in patients with cognitive impairment and/or pain.
    Fayed N; Andrés E; Viguera L; Modrego PJ; Garcia-Campayo J
    Acad Radiol; 2014 Sep; 21(9):1211-7. PubMed ID: 24981958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease.
    Gröger A; Chadzynski G; Godau J; Berg D; Klose U
    Eur Radiol; 2011 Sep; 21(9):1962-9. PubMed ID: 21484351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal pathology in schizophrenia: magnetic resonance imaging and spectroscopy studies.
    Kegeles LS; Shungu DC; Anjilvel S; Chan S; Ellis SP; Xanthopoulos E; Malaspina D; Gorman JM; Mann JJ; Laruelle M; Kaufmann CA
    Psychiatry Res; 2000 May; 98(3):163-75. PubMed ID: 10821999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopic imaging of gray and white matter in bipolar-I and schizophrenia.
    Bustillo JR; Jones T; Qualls C; Chavez L; Lin D; Lenroot RK; Gasparovic C
    J Affect Disord; 2019 Mar; 246():745-753. PubMed ID: 30623820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.